| Net Cash Provided by (Used in) Operating Activities |
$25,893,000 |
USD |
-0.37% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$186,731,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$196,023,000 |
USD |
-5019% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
131,031,455 |
shares |
15% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$75,035,000 |
USD |
8.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$27,899,000 |
USD |
-12% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$600,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$26,969,000 |
USD |
-7% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$17,463,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$33,625,000 |
USD |
-8.4% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$4,850,000 |
USD |
-7.6% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$5,637,000 |
USD |
4.4% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$6,656,000 |
USD |
-13% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$4,646,000 |
USD |
4.4% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,900,000 |
USD |
-6.5% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$4,121,000 |
USD |
-2.7% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Payments |
$5,491,000 |
USD |
2.7% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$39,440,000 |
USD |
13% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$600,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |